Waters... noitazilaicremmoC dna tnempole

Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
Spotlight
上一篇:Surge... sregnessap sseltekcit no nwodk
下一篇:At... airegiN tsewhtuos ni hcruhc ci